Aspire Biopharma Holdings, Inc. (ASBPW)Estero, United States | NasdaqCM
0.02 USD
+0.00
(6.383%)
⇧
(Aug. 28, 2026, 1:33 p.m.
EDT)
|
Hot Take ↕ | Aug. 22, 2026, 5:52 a.m. EDT
The immediate outlook is severely bearish due to a looming Nasdaq delisting threat triggered by compliance failures, which creates significant regulatory and liquidity headwinds. While the company currently holds a massive cash reserve relative to its tiny market capitalization—suggesting a theoretical runway for survival—the operational reality is dire, with gross margins and operating margins deeply negative and no revenue generated. The stock has recently halved in value over a short period, moving from $0.02 to $0.01, indicating active selling pressure rather than accumulation. There is no dividend income to offset these risks, and the lack of historical price data prevents any assessment of long-term business quality or recovery trends. This remains a speculative gamble on a regulatory fix rather than a viable investment thesis. |
| Attribute | Value |
|---|---|
| Revenue per Share | 0.295 |
| Beta | 0.11 |
| Previous Name | Aspire BioPharma, Inc. |
| Website | https://aspirebiolabs.com |
| Attribute | Value |
|---|---|
| Address1 | 23,150 Fashion Drive |
| Address2 | Suite 232 |
| Beta | 0.111 |
| Bid | 0.0206 |
| Bid Size | 4 |
| Book Value | 9.078 |
| City | Estero |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.015 |
| Current Ratio | 7.986 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.015 |
| Day Low | 0.0148 |
| Display Name | Aspire Biopharma |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.015 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.0148 |
| Fifty Two Week Low Change | 0.00019999966 |
| Fifty Two Week Low Change Percent | 0.013513491 |
| Fifty Two Week Range | 0.0148 - 0.015 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 1,118,146 |
| Free Cashflow | 7,431,185 |
| Full Exchange Name | NasdaqCM |
| Fullday Change | 0.0008999994 |
| Fullday Change Percent | 6.382974 |
| Fullday Price | 0.015 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -0.25038 |
| Gross Profits | -24,452 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Language | en-US |
| Last Split Date | 1,778,457,600 |
| Last Split Factor | 1:30 |
| Long Business Summary | Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida. |
| Long Name | Aspire Biopharma Holdings, Inc. |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1860544308 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -11,049,261 |
| Open | 0.0437 |
| Operating Cashflow | -7,185,846 |
| Operating Margins | -38.80584 |
| Phone | 908 987 3002 |
| Prev Name | Aspire BioPharma, Inc. |
| Previous Close | 0.0141 |
| Price Hint | 4 |
| Price To Book | 0.0016523462 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.216 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0008999994 |
| Regular Market Change Percent | 6.382974 |
| Regular Market Day High | 0.015 |
| Regular Market Day Low | 0.0148 |
| Regular Market Day Range | 0.0148 - 0.015 |
| Regular Market Open | 0.0437 |
| Regular Market Previous Close | 0.0141 |
| Regular Market Price | 0.015 |
| Regular Market Time | 1,787,938,382 |
| Regular Market Volume | 8,653 |
| Return On Assets | 0.60576 |
| Return On Equity | -10.32142 |
| Revenue Per Share | 0.295 |
| Sand P52 Week Change | 0.20504117 |
| Sector | |
| Sector Key | |
| Source Interval | 15 |
| State | FL |
| Symbol | ASBPW |
| Total Cash | 12,167,136 |
| Total Cash Per Share | 8.675 |
| Total Debt | 0 |
| Total Revenue | 97,659 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 8,653 |
| Website | https://aspirebiolabs.com |
| Zip | 33,928 |